Cloudbreak Pharma Inc CDBKF
Cloudbreak Pharma Inc. Stock Analysis CDBKF
United States Health Care Micro Cap Cloudbreak Pharma, Inc. is an investment holding company, which engages in the research and development of therapeutic biologics. The company is headquartered in Irvine, California and currently employs 60 full-time employees. The company went IPO on 2025-07-03. The firm is focusing on the in-house discovery, development and commercialization of ophthalmic therapies. The firm has two Core Products, CBT-001 and CBT-009, both of which are being proprietarily developed. Its Core Product, CBT-001, is indicated for the treatment of pterygium (a benign proliferative ocular surface disease), and it has commenced a Phase III multi-regional clinical trial (MRCT) in the United States and China. Its Core Product, CBT-009, is indicated for the treatment of juvenile myopia (myopia in children and adolescents aged 5 to 19) and has completed Phase I/II clinical trials. Its other drug candidates are in a relatively early development stage, including two other clinical-stage drug candidates, which are CBT-006 and CBT-004, and four pre-clinical-stage drug candidates, which are CBT-007, CBT-199, CBT-145, and CBT-011.
Cloudbreak Pharma Inc (CDBKF) Chart
Financial Metrics & Statements of Cloudbreak Pharma Inc (CDBKF)
FAQ's for Cloudbreak Pharma Inc (CDBKF)
- As of August 2026, Cloudbreak Pharma Inc CDBKF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cloudbreak Pharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Cloudbreak Pharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Cloudbreak Pharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Cloudbreak Pharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Cloudbreak Pharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Cloudbreak Pharma Inc (CDBKF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
